Skip to content
Review

Electrocardiographic identification of drug effects: QT prolongation, arrhythmias, and clinical monitoring

Aug 2026 · European Journal of Clinical Pharmacology · Vol 82 · 0 citations · 109 references
Medicine

TL;DR

A systematic narrative review of drug-induced ECG changes, QTc measurement methodology, TdP risk stratification, and ECG monitoring protocols covering January 2006 to April 2026 found evidence that evidence-based monitoring protocols, correction of modifiable risk factors, and prompt recognition of ominous ECG patterns substantially reduce adverse outcomes.

View source

Similar papers

Open access Sep 2026

QT Prolongation, Ventricular Arrhythmia, and Cardiac Arrest Signals During Ceftriaxone Co-therapy with Individual Proton Pump Inhibitors: A Multidatabase Study

The concomitant use of ceftriaxone and proton pump inhibitors (PPIs) is common in hospital practice. However, it is unclear whether individual PPIs differ in their effects on QT interval prolongation, ventricular arrhythmia, or cardiac arrest, collectively termed as QVC events. We conducted a two-stage, real-world stud...

Ye-Chao Chen, Qiao-Ling Gu, Ming Zhao et al. · 0 citations
Review Sep 2026

How Often Do QT-prolonging Drugs Really Prolong QT? A Systematic Review.

OBJECTIVES To systematically evaluate the incidence and prevalence of drug-induced QT interval prolongation and torsades de pointes (TdP) among adults exposed to QT-prolonging medications. DESIGN Systematic review of observational and interventional studies identified through MEDLINE (via PubMed). SETTING Primary a...

Dragos-Paul Hagiu, Lina Hamdi, Edouard Ollier et al. · 0 citations
Open access Sep 2026

QT interval prolongation in the coronary intensive care unit: prevalence, associated drugs and clinical-genetic risk factors.

We aimed to investigate the prevalence of QTc interval prolongation (QTcIP), QTc-prolonging drug exposure, and associated clinical and genetic risk factors in adult patients hospitalized in the Coronary Intensive Care Unit. This observational cohort study included 207 patients hospitalized for ≥24 h. Clinical, laborato...

Gozde Akturk, A. A. Başkurt, A. Çağlayan et al. · 0 citations
Review Open access Sep 2026

Antiemetic-Associated QT Prolongation: A Clinical Review and Risk-Stratified Prescribing Framework for Long QT Syndrome.

BACKGROUND AND AIMS Nausea and vomiting accompany pregnancy, gastroenteritis, migraine, the perioperative period, and cytotoxic chemotherapy, and antiemetics are among the most frequently prescribed drugs worldwide. Several antiemetic classes delay ventricular repolarization and prolong the QT interval, a substrate for...

A. Moustafa, Omar Dabash, P. Panigrahi et al. · 0 citations
Review Open access Sep 2026

Congenital Long QT Syndrome: From Conventional Management to Emerging Biological Therapies

Congenital long QT syndrome (LQTS), the first identified cardiac ion channelopathy, is characterized by delayed ventricular repolarization and a prolonged heart rate-corrected QT interval (QTc), conferring an increased risk of malignant ventricular arrhythmias and sudden cardiac death. Current standard-of-care manageme...

Qing Liu, Yi-Fei Wang, Ping Zhang et al. · 0 citations
Review Open access Sep 2026

Fragmented QRS: Electrophysiological Bases, Pathophysiological Mechanisms, and Clinical Prognostic Significance

Background: Fragmented QRS (fQRS) is characterized by morphological irregularities in ventricular depolarization on a standard 12-lead surface electrocardiogram (ECG) and is considered a non-invasive indicator of myocardial conduction heterogeneity. Microstructural changes such as non-uniform anisotropy, gap junction r...

S. Koroglu, E. Aksu, Ekrem Gemci · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.